Search for: "Mylan Pharmaceuticals" Results 61 - 80 of 738
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 Dec 2021, 7:15 am by Logan Murr
The decision relates to AstraZeneca AB’s and AstraZeneca Pharmaceuticals LP’s (collectively “AstraZeneca”) lawsuit against Mylan and Kindeva Drug Delivery LP (collectively “Mylan”) for infringing all claims of U.S. [read post]
8 Dec 2021, 8:52 am by Lawrence B. Ebert
The outcome AstraZeneca AB and AstraZeneca Pharmaceuticals LP (collectively, “AstraZeneca”) sued Mylan Pharmaceuticals Inc. and Kindeva Drug Delivery L.P. [read post]
8 Nov 2021, 9:15 am by Steve Brachmann
Mylan Pharmaceuticals Inc. affirming a ruling of the District of Delaware, which dismissed a Hatch-Waxman lawsuit against related Mylan entities for either improper venue or failure to state a claim upon which relief could be granted. [read post]
8 Nov 2021, 9:15 am by Steve Brachmann
Mylan Pharmaceuticals Inc. affirming a ruling of the District of Delaware, which dismissed a Hatch-Waxman lawsuit against related Mylan entities for either improper venue or failure to state a claim upon which relief could be granted. [read post]
8 Nov 2021, 9:15 am by Steve Brachmann
Mylan Pharmaceuticals Inc. affirming a ruling of the District of Delaware, which dismissed a Hatch-Waxman lawsuit against related Mylan entities for either improper venue or failure to state a claim upon which relief could be granted. [read post]
6 Oct 2021, 12:59 pm by Rebecca Tushnet
There wasn’t enough evidence about duration on (5), and on (6), Sanofi was a big pharmaceutical company that could have fought back in the market with its teams of sales reps. [read post]
17 Sep 2021, 11:35 am by Mark Astarita
Mallu, of Orlando, Florida, who generated gains and avoided losses totaling over $8 million by trading in the securities of his former employer, Mylan N.V…Read the Full Press ReleaseHave a securities law question? [read post]
5 Aug 2021, 7:38 pm by Patent Docs
The product is Semglee (insulin glargine-yfgn), produced by Mylan Pharmaceuticals, Inc., and under this approval, it is interchangeable with Lantus (insulin glargine) made by Sanofi. [read post]
17 May 2021, 12:45 am by Annsley Merelle Ward
  Unjust enrichment of pharmaceutical company towards health insurerMenzis / AstraZeneca, District Court of The Hague 14 October 2020 (Judge Knijff, Brinkman and Aalbers) [Dutch decision here]The second half of 2020 brought a remarkable decision in a case between health insurance company Menzis and pharmaceutical company AstraZeneca. [read post]
13 May 2021, 11:44 pm
Ebenezer Scrooge and Marley's GhostJane LambertPatents Court (Mr Justice Matcus Smith) Neurim Pharmaceuticals (1991) Ltd and Another v Generics UK Ltd (t/a Mylan) and another  [2021] EWHC 530 (Pat) (12 March 2021)This was an action by Neurim Pharmaceuticals (1991) Ltd ("Neurim") the proprietor of European patent (UK) 1 441 702 B1  and Flynn Pharma Ltd ("Flynn"), its purported exclusive licensee, [read post]
22 Apr 2021, 7:02 am by David W.S. Lieberman
Streck was an executive with more than 30 years of experience in the pharmaceutical industry. [read post]